Marshall Wace, LLP En V Veno Medical Corp Transaction History

Marshall Wace, LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$3.94 - $6.65 $97,790 - $165,053	24,820 Added 162.22%	40,120 $218,000
Q4 2023 Feb 14, 2024	BUY	$3.46 - $5.73 $52,938 - $87,669	15,300 New	15,300 $78,000
Q4 2021 Feb 14, 2022	SELL	$6.23 - $10.24 $76,049 - $124,999	-12,207 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.65 - $10.59 $68,969 - $129,272	12,207 New	12,207 $127,000

3.73M

98.5K

6.1K

Ticker NVNO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 9,469,850
Market Cap $30.7M
Description
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.